120 related articles for article (PubMed ID: 7345881)
1. Effects of hydroflumethiazide in congestive heart failure: renal electrolyte excretion related to urinary thiazide excretion and aldosterone.
Brørs O; Enger E; Jacobsen S; Aakvaag A; Foss OP
Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):399-406. PubMed ID: 7345881
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated doses of hydroflumethiazide on renal excretion of electrolytes and uric acid in healthy subjects.
Brørs O; Jacobsen S; Foss OP; Aakvaag A
Acta Pharmacol Toxicol (Copenh); 1981 Feb; 48(2):145-50. PubMed ID: 7257825
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of hydroflumethiazide during repeated administration in congestive heart failure.
Brørs O
Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):177-81. PubMed ID: 7136723
[TBL] [Abstract][Full Text] [Related]
4. Effect of high-dose aldosterone infusions on renal electrolyte excretion in patients with renal insufficiency.
Hené RJ; Koomans HA; Boer P; Dorhout Mees EJ
Am J Nephrol; 1987; 7(1):33-7. PubMed ID: 3578372
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
Hypertension; 1992 Jul; 20(1):80-4. PubMed ID: 1535613
[TBL] [Abstract][Full Text] [Related]
6. [STUDY ON ALDOSTERONE AND ELECTROLYTE METABOLISM IN CARDIAC INSUFFICIENCY].
NAGAI I
Nihon Naibunpi Gakkai Zasshi; 1964 Feb; 39():1013-30. PubMed ID: 14144600
[No Abstract] [Full Text] [Related]
7. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
[TBL] [Abstract][Full Text] [Related]
8. Relationship of urinary kallikrein excretion to renal water and sodium excretion.
Ueno M; Kawasaki T; Uezono K; Omae T; Matsuoka M
Metabolism; 1983 May; 32(5):433-7. PubMed ID: 6551657
[TBL] [Abstract][Full Text] [Related]
9. Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group.
Patterson JH; Adams KF; Applefeld MM; Corder CN; Masse BR
Pharmacotherapy; 1994; 14(5):514-21. PubMed ID: 7997385
[TBL] [Abstract][Full Text] [Related]
10. [Use of aldactone-saltucine in patients with heart failure].
Bobkova VI; Kartitskií VS; Lapkes TG; Mazurova SV
Kardiologiia; 1975 May; 15(5):105-8. PubMed ID: 1152318
[TBL] [Abstract][Full Text] [Related]
11. Demeclocycline-induced natriuresis and renal insufficiency: in vivo and in vitro studies.
Braden GL; Geheb MA; Shook A; Singer I; Cox M
Am J Kidney Dis; 1985 May; 5(5):270-7. PubMed ID: 3923829
[TBL] [Abstract][Full Text] [Related]
12. Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympathoadrenergic tone, and intratubular factors.
Trevisani F; Bernardi M; De Palma R; Pancione L; Capani F; Baraldini M; Ligabue A; Gasbarrini G
Gastroenterology; 1989 Apr; 96(4):1187-98. PubMed ID: 2925063
[TBL] [Abstract][Full Text] [Related]
13. The circadian rhythm of renal excretion in the rat: relationship between electrolyte and corticosteroid excretion.
Hilfenhaus M; Herting T
Contrib Nephrol; 1980; 19():56-62. PubMed ID: 7379546
[TBL] [Abstract][Full Text] [Related]
14. Time-related changes in urinary aldosterone and electrolyte excretion during amiloride administration to congestive heart failure patients [proceedings].
Counihan TB; Dunne A; Ryan MF; Ryan MP
Br J Pharmacol; 1979 Nov; 67(3):494P. PubMed ID: 497604
[No Abstract] [Full Text] [Related]
15. Metoclopramide stimulates kaliuresis during felodipine without affecting its natriuresis.
van Hamersvelt HW; Wetzels JF; Koene RA; Huysmans FT
Hypertension; 1994 Nov; 24(5):633-9. PubMed ID: 7960025
[TBL] [Abstract][Full Text] [Related]
16. Cardiorenal effects of atrial natriuretic factor administration in congestive heart failure: natriuresis and diuresis without hemodynamic alterations.
Firth BG; Perna R; Bellomo JF; Toto RD
Am J Med Sci; 1989 Apr; 297(4):203-8. PubMed ID: 2565086
[TBL] [Abstract][Full Text] [Related]
17. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
[TBL] [Abstract][Full Text] [Related]
19. Excretion of hydroflumethiazide in bile and urine of man.
Brørs O; Haffner JF; Jacobsen S
Eur J Clin Pharmacol; 1979 May; 15(4):287-9. PubMed ID: 477714
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
